Причина отмены This specification covers the identification of the drug contained in the prefilled syringe or delivery system and the concentration, volume, and total amount of the drug, and whether it is to be diluted prior to administration.

Formerly under the jurisdiction of Committee F02 on Flexible Barrier Packaging, this specification was withdrawn in August 2022 because of limited use by industry.

Реферат

This specification covers the identification of: drug contained in the prefilled syringe or delivery sysetm and the concentration, volume, and total amount of the drug, and whether it is to be diluted prior to administration. The label copy shall comply with the specified requirements. Delivery systems shall not resemble a normal syringe and shall be unsuitable for direct intravenous line injection. The copy for the proprietary name or established name of the drug shall be legible in accordance with the legibility test.

Область применения

1.1 This specification covers the identification of:

1.1.1 The drug contained in the prefilled syringe or delivery system.

1.1.2 The concentration, volume, and total amount of the drug, and whether it is to be diluted prior to administration.

1.2 The values stated in either SI units or inch-pound units are to be regarded separately as standard. The values stated in each system may not be exact equivalents; therefore, each system shall be used independently of the other. Combining values from the two systems may result in non-conformance with the standard.

Note 1: The values in SI units are the recommended values.